Read our April issue!.This month we're exploring the impact of a #DEI ban on the #clinicalresearch ecosystem, tapping the #patientvoice as a strategic differentiator, the value of clinical trial liaisons in the #drugdevelopment lifecycle, and much more.

The 2025 Applied Clinical Trials® State of the Industry Survey is here!. We’re gathering insights from clinical operations professionals to understand the biggest pressures facing trial execution today. Use your voice:

IS1 uses "Market Match" to connect life science companies with trusted development and manufacturing partners to accelerate innovation through strategic, lifecycle-aligned collaborations. Download our 2025 media kit or contact us today to learn more:.

Enhancing Obesity Trials with Integrated eCOA and Digital Endpoint Technologies. Discover successful integration strategies, use cases demonstrating better data and patient outcomes, and the future of digital tools in obesity research. Register now:

Enhancing Obesity Trials with Integrated eCOA and Digital Endpoint Technologies. Join industry experts to discover how integrating eCOA's with digital endpoints can improve data accuracy, patient compliance, and trial efficiency. Register now:

\Mark Rodgers discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access. Download podcast and Q&A:

Complex Trials, Clear Budgets: Accelerating Budget Finalization in Global Clinical Trials. Still finalizing clinical trial budgets manually? Join this live webinar to discover how technology is transforming clinical trial budgeting. Register now:

Complex Trials, Clear Budgets: Accelerating Budget Finalization in Global Clinical Trials. Clinical trial budgets are more complex than ever. Join our webinar to explore strategies that speed budget finalization and streamline study start-up. Register now:

Innovative Clinical Outcome Assessment (COA) Solutions for Obesity Trials: Measuring Matters. Join our live webinar to see how innovative COA solutions transform obesity trials, boosting efficiency and speeding treatments. Register now:

Innovative Clinical Outcome Assessment (COA) Solutions for Obesity Trials: Measuring Matters. Ready to elevate your clinical trials? Join our live webinar to see how COA solutions and connected devices enhance efficiency and outcomes. Register now:

At SCOPE Summit 2025, uMotif CEO Steve Rosenberg shared insights on transforming the patient and site experience in clinical trials. Learn how innovative strategies are shaping the future of clinical trials in this exclusive booth video. Watch the Video:

Click through the issue here: Check out our interactive issue here:

The future of clinical trial design involves incorporating the patient experience into strategic asset planning.

Thierry Escudier, portfolio lead, @PistoiaAlliance , highlights the need for maintaining #dataprivacy in a highly regulated #clinicalresearch industry.

Study uncovers insights on the impact on safety, patient enrollment/retention, and compliance.

Anticipating divestment, reallocation of investments, and retrenchment. Ken Getz, MBA, Executive Director and Research Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine.

The challenges, opportunities, and strategic outlook for oncology research centers.

Thierry Escudier, portfolio lead, @PistoiaAlliance, talks the current landscape of #sustainability in #clinicaltrials and how stakeholders are beginning to pay more attention to carbon footprint amid increasing protocol complexity.

Exploring the different stages in the development of a digital measure, and the activities and steps key to achieving meaningful impact for patients.

Why investing in truly effective training from the outset can pay off exponentially for clinical teams—and serve as a strategic advantage.